Lumigan Versus Cosopt

PHASE4CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

January 31, 2006

Study Completion Date

May 31, 2007

Conditions
Open-Angle Glaucoma
Interventions
DRUG

bimatoprost 0.03%

DRUG

dorzolamide 2%/timolol maleate 0.5% fixed combination

DRUG

placebo

Trial Locations (3)

29464

Glaucoma Consultants & Center for Eye Research, PA, Mt. Pleasant

40217

Taustine Eye Center, Louisville

77025

Houston Eye Associates, Houston

All Listed Sponsors
lead

Pharmaceutical Research Network

OTHER